High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial

Summary Background The current standard treatment for patients with high-risk neuroblastoma includes initial induction chemotherapy with a 21-day interval between induction treatments. We aimed to assess whether an intensive chemotherapy protocol that had a 10-day interval between treatments would i...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The lancet oncology 2008-03, Vol.9 (3), p.247-256
Hauptverfasser:	Pearson, Andrew DJ, Prof, Pinkerton, C Ross, Prof, Lewis, Ian J, FRCP, Imeson, John, MSc, Ellershaw, Caroline, BA, Machin, David, Prof
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bone marrow Chemotherapy Child Child, Preschool Disease-Free Survival Drug Administration Schedule Drug dosages Female Hematology Hematology, Oncology and Palliative Medicine Humans Infant Male Medical prognosis Neuroblastoma Neuroblastoma - drug therapy Neuroblastoma - mortality Neuroblastoma - pathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!